RecruitingNot applicableNCT06022016
Study of Families With an Hemopathies Predisposition Related to the DDX41 Gene.
Studying DDX41-related hematologic malignancy predisposition syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Institut Claudius Regaud
- Intervention
- For each person (index case or related) included in this study:(genetic)
- Enrollment
- 910 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2030
Study locations (5)
- Chu de Bordeaux, Bordeaux, France
- Chu de Limoges, Limoges, France
- Institut Paoli-Calmettes, Marseille, France
- Chu de Montpellier, Montpellier, France
- IUCT-O, Toulouse, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06022016 on ClinicalTrials.gov